Skip to main content
SpringerLink
Log in

Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry

  • Original Article
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Abstract

The treatment of elderly patients with coronary artery disease (CAD) is challenging because this population is complex and greatly expanding. Drug-eluting stents (DES) generally improve the outcome in high-risk cases. We evaluated the clinical impact of different first-generation DES, i.e., sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES), in this context. A prospective, nonrandomized, single-center, allcomers registry consecutively enrolling all patients aged ≥75 years eligible for percutaneous coronary intervention (PCI) with DES was carried out. Only one type of DES was implanted per protocol for each patient. Two groups were identified according to the type of implanted stent, i.e., SES and PES. The primary end point encompassed major adverse cardiac events (MACE), including death, myocardial infarction, and target lesion revascularization (TLR). The secondary end point encompassed the rate of definite/probable stent thrombosis and target vessel revascularization (TVR). From June 2004 to May 2008, 151 patients were enrolled. Among them, 112 (74.2%) received SES and 39 (25.8%) received PES. Baseline clinical characteristics were similar, while few angiographic features (ostial location, stent diameter, proximal reference vessel diameter) showed minor differences. At the median follow-up of 22.6 months, primary and secondary end points did not significantly differ in terms of MACE (SES 12.5% vs PES 20.5%, P = 0.3), death (SES 5.4% vs PES 7.7%, P = 0.7), myocardial infarction (SES 4.5% vs PES 10.3%, P = 0.2), TLR (SES 2.7% vs PES 2.6%, P = 1.0), stent thrombosis (SES 1.8% vs PES 5.1%, P = 0.3), and TVR (SES 1.8% vs PES 0%, P = 0.6). In this real-world population of elderly patients treated by DES–PCI for CAD, the overall efficacy and safety have been excellent in both DES, and the choice between SES and PES did not influence the clinical outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM, American Heart Association Council on Clinical Cardiology; Society of Geriatric Cardiology (2007) Acute coronary care in the elderly, part 1: non-ST-segment-elevation cute coronary syndromes: a scientific statement for healthcare professions from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation 115:2549–2569

    Article  PubMed  Google Scholar 

  2. Incidence and prevalence: 2006 chart book on cardiovascular and lung diseases. National Heart, Lung, and Blood Institute; 2006

  3. Costa JR Jr, Sousa A, Moreira AC, Costa RA, Maldonado G, Cano MN, Egito ET, Romano ER, Barbosa M, Pavanello R, Jardim C, Cury A, Berwanger O, Sousa JE (2008) Drug-eluting stents in the elderly: long-term (>one year) clinical outcomes of octogenarians in the DESIRE (Drug Eluting Stents In the Real world) Registry. J Invasive Cardiol 20:404–410

    PubMed  Google Scholar 

  4. Hong YJ, Jeong MH, Choi YH, Ma EH, Ko JS, Lee MG, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC (2008) Age-related differences in intravascular ultrasound findings in 1,009 coronary artery disease patients. Circ J 72:1270–1275

    Article  PubMed  Google Scholar 

  5. Badran HM, Elnoamany MF, Khalil TS, Ezz Eldin MM (2009) Age-related alteration of risk profile, inflammatory response, and angiographic findings in patients with acute coronary syndrome. Clin Med Cardiol 3:15–28

    PubMed  Google Scholar 

  6. Greenhalgh J, Hockenhull J, Rao N, Dundar Y, Dickson RC, Bagust A (2010) Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes. Cochrane Database Syst Rev 5:CD004587 (review)

    Google Scholar 

  7. Kirtane AJ, Gupta A, Iyengar S, Moses JW, Leon MB, Applegate R, Brodie B, Hannan E, Harjai K, Jensen LO, Park SJ, Perry R, Racz M, Saia F, Tu JV, Waksman R, Lansky AJ, Mehran R, Stone GW (2009) Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 119:3198–3206

    Article  PubMed  CAS  Google Scholar 

  8. Roukoz H, Bavry AA, Sarkees ML, Mood GR, Kumbhani DJ, Rabbat MG, Bhatt DL (2009) Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up. Am J Med 122:581.e1–581.e10

    Google Scholar 

  9. Brar SS, Leon MB, Stone GW, Mehran R, Moses JW, Brar SK, Dangas G (2009) Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 53:1677–1689

    Article  PubMed  Google Scholar 

  10. Douglas PS, Brennan JM, Anstrom KJ, Sedrakyan A, Eisenstein EL, Haque G, Dai D, Kong DF, Hammill B, Curtis L, Matchar D, Brindis R, Peterson ED (2009) Clinical effectiveness of coronary stents in the elderly: results from 262,700 Medicare patients in ACC-NCDR. J Am Coll Cardiol 53:1629–1641

    Article  PubMed  Google Scholar 

  11. McKellar SH, Brown ML, Frye RL, Schaff HV, Sundt TM 3rd (2008) Comparison of coronary revascularization procedures in octogenarians: a systematic review and meta-analysis. Nat Clin Pract Cardiovasc Med 5:738–746

    Article  PubMed  Google Scholar 

  12. Klein LW, Block P, Brindis RG, McKay CR, McCallister BD, Wolk M, Weintraub W, ACC-NCDR Registry (2002) Percutaneous coronary interventions in octogenarians in the American College of Cardiology–National Cardiovascular Data Registry. J Am Coll Cardiol 40:394–402

    Article  PubMed  Google Scholar 

  13. Johnman C, Oldroyd KG, Mackay DF, Slack R, Pell AC, Flapan AD, Jennings KP, Eteiba H, Irving J, Pell JP (2010) Percutaneous coronary intervention in the elderly changes in case-mix and periprocedural outcomes in 31758 patients treated between 2000 and 2007. Circ Cardiovasc Interv 3:1–5

    Article  Google Scholar 

  14. Dynina O, Vakili BA, Slater JN, Sherman W, Ravi KL, Green SJ, Sanborn TA, Brown DL (2003) In-hospital outcomes of contemporary percutaneous coronary interventions in the very elderly. Cathet Cardiovasc Intervent 58:351–357

    Article  Google Scholar 

  15. Forman DE, Cox DA, Ellis SG, Lasala JM, Ormiston JA, Stone GW, Turco MA, Wei JY, Joshi AA, Dawkins KD, Baim DS (2009) Long term paclitaxel-eluting stent outcomes in elderly patients. Circ Cardiovasc Intervent 2:178–187

    Article  CAS  Google Scholar 

  16. Wiemer M, Langer C, Kottmann T, Horstkotte D, Hamm C, Pfannebecker TH, Tebbe U, Schneider S, Senges J (2007) Outcome in the elderly undergoing percutaneous coronary intervention with sirolimus-eluting stents: results from the prospective multicenter German Cypher Stent Registry. Am Heart J 154:682–687

    Article  PubMed  CAS  Google Scholar 

  17. Floyd KC, Jayne JE, Kaplan AV, Friedman BJ, Niles NW, Hettleman BD, Robb JF, Thompson CA (2006) Age-based differences of percutaneous coronary intervention in the drug-eluting stent era. J Interv Cardiol 19:381–387

    Article  PubMed  Google Scholar 

  18. Sardella G, De Luca L, De Persio G, Colantonio R, Petrolini A, Conti G, Fedele F (2007) Benefits on coronary restenosis from elective paclitaxel-eluting stent implantation in patients aged 75 years and older. J Cardiovasc Med 8:494–498

    Article  Google Scholar 

  19. Groeneveld PW, Matta MA, Greenhut AP, Yang F (2008) Drug-eluting compared with bare-metal coronary stents among elderly patients. J Am Coll Cardiol 51:2017–2024

    Article  PubMed  CAS  Google Scholar 

  20. Sanfilippo A, Cumbo M, Caggegi AM, Monaco S, Bucalo R, Ruperto C, Tamburino C, Ussia GP, Galassi AR, Capranzano P, Capodanno D, Tamburino C (2009) Long term outcomes comparison of different type of DES in elderly patients from a real-world experience. J Invasive Cardiol 21:330–333

    PubMed  Google Scholar 

  21. Popma JJ, Bashoretd (1994) Qualitative and quantitative angiography. In: Topol E (ed) Textbook of interventional cardiology. Saunders, Philadelphia, pp 1052–1068

  22. Smith SC Jr, Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, Kuntz RE, Popma JJ, Schaff HV, Williams DO, Gibbons RJ, Alpert JP, Eagle KA, Faxon DP, Fuster V, Gardner TJ, Gregoratos G, Russell RO, Smith SC Jr, American College of Cardiology; American Heart Association Task Force on Practice Guidelines. Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty (2001) Guidelines for percutaneous transluminal angioplasty; a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol 37:2215–3229

    Article  PubMed  Google Scholar 

  23. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium (2007) Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115:2344–2351

    Article  PubMed  Google Scholar 

  24. Assali AR, Moustapha A, Sdringola S, Salloum J, Awadalla H, Saikia S, Ghani M, Hale S, Schroth G, Rosales O, Anderson HV, Smalling RW (2003) The dilemma of success: percutaneous coronary interventions in patients > or = 75 years of age-successful but higher vascular complications and cardiac mortality. Catheter Cardiovasc Interv 59:195–199

    Article  PubMed  Google Scholar 

  25. Vlaar PJ, Lennon RJ, Rihal CS, Singh M, Ting HH, Bresnahan JF, Holmes DR Jr (2008) Drug-eluting stent in octogenarians: early and intermediate outcome. Am Heart J 155:680–686

    Article  PubMed  CAS  Google Scholar 

  26. Shirasawa K, Hwang MW, Sasaki Y, Takeda S, Inenaga-Kitaura K, Kitaura Y, Kawai C (2011) Survival and changes in physical ability after coronary revascularization for octa-nonagenerian patients with acute coronary syndrome. Heart Vessels 26:385–391

    Article  PubMed  Google Scholar 

  27. Ryan J, Linde-Zwirble W, Engelhart L, Cooper L, Cohen DJ (2009) Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare program. Circulation 119:952–961

    Article  PubMed  Google Scholar 

  28. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S (2006) Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 114:774–782

    Article  PubMed  Google Scholar 

  29. Ndrepepa G, Keta D, Schulz S, Mehilli J, Birkmeier A, Neumann FJ, Schömig A, Kastrati A (2010) Characterization of patients with bleeding complications who are at increased risk of death after percutaneous coronary intervention. Heart Vessels 25:294–298

    Article  PubMed  Google Scholar 

  30. Zhang F, Dong L, Ge J (2010) Meta-analysis of five randomized clinical trials comparing sirolimus- versus paclitaxel-eluting stents in patients with diabetes mellitus. Am J Cardiol 105:64–68

    Article  PubMed  CAS  Google Scholar 

  31. Gurm HS, Boyden T, Welch KB (2008) Comparative safety and efficacy of a sirolimus-eluting versus paclitaxel-eluting stent: a meta-analysis. Am Heart J 155:630–639

    Article  PubMed  CAS  Google Scholar 

  32. Millauer N, Jüni P, Hofmann A, Wandel S, Bhambhani A, Billinger M, Urwyler N, Wenaweser P, Hellige G, Räber L, Cook S, Vogel R, Togni M, Seiler C, Meier B, Windecker S (2011) Sirolimus versus paclitaxel coronary stents in clinical practice. Catheter Cardiovasc Interv 77:5–12

    Article  PubMed  Google Scholar 

  33. Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A (2007) A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol 50:1373–1380

    Article  PubMed  Google Scholar 

  34. Biondi-Zoccai GG, Lotrionte M, Abbate A, Valgimigli M, Testa L, Burzotta F, Crea F, Agostoni P (2007) Direct and indirect comparison meta-analysis demonstrates the superiority of sirolimus- versus paclitaxel-eluting stents across 5854 patients. Int J Cardiol 114:104–115

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, Department of Cardiac Thoracic and Vascular Sciences, University of Padua Medical School, Via Giustiniani 2, 35128, Padua, Italy

    Paolo Buja, Davide Lanzellotti, Giambattista Isabella, Massimo Napodano, Marco Panfili, Enrico Favaretto, Sabino Iliceto & Giuseppe Tarantini

Authors
  1. Paolo Buja
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Davide Lanzellotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giambattista Isabella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Massimo Napodano
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marco Panfili
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Enrico Favaretto
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Sabino Iliceto
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Giuseppe Tarantini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Buja.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buja, P., Lanzellotti, D., Isabella, G. et al. Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry. Heart Vessels 27, 553–558 (2012). https://doi.org/10.1007/s00380-011-0194-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00380-011-0194-5

Keywords

Search

Navigation